BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11241532)

  • 1. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia.
    Chen CP; Chern SR; Shih JC; Wang W; Yeh LF; Chang TY; Tzen CY
    Prenat Diagn; 2001 Feb; 21(2):89-95. PubMed ID: 11241532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of K650E mutation in FGFR3 using uncultured amniocytes in a pregnancy affected with fetal cloverleaf skull, occipital pseudoencephalocele, ventriculomegaly, straight short femurs, and thanatophoric dysplasia type II.
    Chen CP; Chang TY; Lin MH; Chern SR; Su JW; Wang W
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):420-5. PubMed ID: 24075385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia.
    Wilcox WR; Tavormina PL; Krakow D; Kitoh H; Lachman RS; Wasmuth JJ; Thompson LM; Rimoin DL
    Am J Med Genet; 1998 Jul; 78(3):274-81. PubMed ID: 9677066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis of hydrancephaly and enlarged cerebellum and cisterna magna in a fetus with thanatophoric dysplasia type II and a review of prenatal diagnosis of brain anomalies associated with thanatophoric dysplasia.
    Chen CP; Chang TY; Lin TW; Chern SR; Chen SW; Lai ST; Chuang TY; Wang W
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):119-122. PubMed ID: 29458880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA.
    Chitty LS; Khalil A; Barrett AN; Pajkrt E; Griffin DR; Cole TJ
    Prenat Diagn; 2013 May; 33(5):416-23. PubMed ID: 23408600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results.
    Sawai H; Komori S; Ida A; Henmi T; Bessho T; Koyama K
    Prenat Diagn; 1999 Jan; 19(1):21-4. PubMed ID: 10073901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal imaging findings of a fetus with Pfeiffer syndrome and a heterozygous c.1019A>G, p.Tyr340Cys (Y340C) mutation in FGFR2 presenting a cloverleaf skull, craniosynostosis and short limbs on prenatal ultrasound mimicking thanatophoric dysplasia type II.
    Chen CP; Huang JP; Huang KS; Chen YY; Wu FT; Pan YT; Chiu CL; Wang W
    Taiwan J Obstet Gynecol; 2024 May; 63(3):387-390. PubMed ID: 38802203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1).
    Rousseau F; el Ghouzzi V; Delezoide AL; Legeai-Mallet L; Le Merrer M; Munnich A; Bonaventure J
    Hum Mol Genet; 1996 Apr; 5(4):509-12. PubMed ID: 8845844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal imaging findings and molecular genetic analysis of thanatophoric dysplasia type 1 in a fetus with a c.2419T>G (p.Ter807Gly) (X807G) mutation in FGFR3.
    Chen SW; Chen CP; Wang LK; Chern SR; Wu PC; Chen YN; Lin CJ; Chen WL; Wang W
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):87-92. PubMed ID: 28254233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation.
    Jung M; Park SH
    Exp Mol Pathol; 2017 Apr; 102(2):290-295. PubMed ID: 28249712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations.
    Brodie SG; Kitoh H; Lachman RS; Nolasco LM; Mekikian PB; Wilcox WR
    Am J Med Genet; 1999 Jun; 84(5):476-80. PubMed ID: 10360402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
    De Biasio P; Prefumo F; Baffico M; Baldi M; Priolo M; Lerone M; Tomà P; Venturini PL
    Prenat Diagn; 2000 Oct; 20(10):835-7. PubMed ID: 11038465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of thanatophoric dysplasia by 3-D helical computed tomography and genetic analysis.
    Tsutsumi S; Sawai H; Nishimura G; Hayasaka K; Kurachi H
    Fetal Diagn Ther; 2008; 24(4):420-4. PubMed ID: 18987480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thanatophoric dysplasia type I.
    Chang TK; Wang Y; Liu AM; Tung JC
    Acta Paediatr Taiwan; 2001; 42(1):39-41. PubMed ID: 11270184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
    Tavormina PL; Shiang R; Thompson LM; Zhu YZ; Wilkin DJ; Lachman RS; Wilcox WR; Rimoin DL; Cohn DH; Wasmuth JJ
    Nat Genet; 1995 Mar; 9(3):321-8. PubMed ID: 7773297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia.
    Katsumata N; Kuno T; Miyazaki S; Mikami S; Nagashima-Miyokawa A; Nimura A; Horikawa R; Tanaka T
    Endocr J; 1998 Apr; 45 Suppl():S171-4. PubMed ID: 9790257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual radiological finding in thanatophoric dysplasia type 1 with common mutation of the fibroblast growth factor receptor-3 (FGFR3) gene (Arg248Cys).
    Camera G; Baldi M; Baffico M; Pozzolo S
    Am J Med Genet; 1997 Jul; 71(1):122-3. PubMed ID: 9215781
    [No Abstract]   [Full Text] [Related]  

  • 18. Thanatophoric dysplasia type II with encephalocele and semilobar holoprosencephaly: Insights into its pathogenesis.
    Martínez-Frías ML; Egüés X; Puras A; Hualde J; de Frutos CA; Bermejo E; Nieto MA; Martínez S
    Am J Med Genet A; 2011 Jan; 155A(1):197-202. PubMed ID: 21204232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thanatophoric dysplasia type I associated with increased nuchal translucency in the first trimester: Early prenatal diagnosis using combined ultrasonography and molecular biology.
    Tonni G; Azzoni D; Ventura A; Ferrari B; Felice CD; Baldi M
    Fetal Pediatr Pathol; 2010; 29(5):314-22. PubMed ID: 20704477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
    Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
    Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.